Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ZT002 injection in adults with overweight or obesity
CTR20242527Phase 2Completed
- Sponsor
- Quality Peptide
- Start
- Jul 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of zovaglutide in obesity, Overweight, sponsored by Quality Peptide. Started Jul 2024; status: completed.
02
Drugs
zovaglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20242527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242527.